Autolus Therapeutics Plc (AUTL)
1.59
+0.06
(+3.92%)
USD |
NASDAQ |
Dec 11, 16:00
1.60
+0.01
(+0.63%)
After-Hours: 07:20
Autolus Therapeutics Free Cash Flow: -306.93M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Adaptimmune Therapeutics Plc | -193.83M |
| Biodexa Pharmaceuticals Plc | -14.30M |
| NuCana Plc | -18.19M |
| Mereo BioPharma Group Plc | -33.02M |
| Bicycle Therapeutics Plc | -242.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -67.40M |
| Cash from Investing (Quarterly) | 35.49M |
| Cash from Financing (Quarterly) | -1.777M |
| Free Cash Flow Per Share (Quarterly) | -0.3001 |
| Free Cash Flow to Equity (Quarterly) | -89.88M |
| Free Cash Flow to Firm (Quarterly) | -69.34M |
| Free Cash Flow Yield | -72.53% |